Find Out If You Have a Case

Attorney Matthew T. Marin

Free, confidential review by Attorney Matthew T. Marin. Prefer to talk? Call (888) 348-2735.

Super Lawyers® 2014–2024CALL 24/7(888) 348-2735

Dupixent Lawsuit — Free, Confidential Case Review

A rash that won’t clear on Dupixent? Trust your instincts.

Patches, plaques, or “stubborn eczema” that keeps spreading are the warning signs doctors describe. If you were diagnosed, two confidential minutes tells you what to do next.

ACTIVE LITIGATION — NO SETTLEMENT. MDL 3180 underway · filing deadlines vary by state.

Were you — or someone you love — diagnosed with CTCL or another T-cell lymphoma after taking Dupixent?

Check if my case qualifiesfree · confidential · takes 2 minutes
I’m not sure of my exact diagnosis →

No documents needed · confidential · an answer either way · no fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

Attorney Matthew T. MarinOr talk to a person now: (888) 348-2735 — answered 24/7

Attorneys Stefanie A. Murphy and Matthew T. Marin of Marin & Murphy Law Firm

Stefanie A. Murphy & Matthew T. Marin

Partners

Every Dupixent inquiry gets a personal review — and an honest answer either way, free and without obligation.

Claims are brought against Sanofi and Regeneron, the makers of Dupixent — not against your doctor. Conversations are confidential. Some matters may be referred to other lawyers. No settlement has been reached, and most cases are in their earliest stages; every case must be proven on its own facts. Attorney Advertising.

The skin changes people describe before a cutaneous T-cell lymphoma diagnosis are ordinary-sounding: patches that keep coming back in the same place, a rash that never fully heals, and itching treatment does not touch. None of that means lymphoma — those things are far more often something else. What follows is here to help you recognize your own history and take it to a doctor.

This page is about a lawsuit — it is not medical advice, and filing a claim does not require you to stop taking Dupixent. Decisions about your medication belong with you and your doctor.

Lawsuits consolidated in MDL 3180 (D.N.J.) allege that Dupixent (dupilumab) is associated with an increased risk of cutaneous T-cell lymphoma (CTCL) and that the manufacturers failed to warn about it. No court has ruled on these allegations, no settlement exists, and the litigation is in its earliest stages. Published studies report a statistical association — which the study authors themselves note does not establish causation — and the FDA has identified a potential safety signal it is still evaluating; Dupixent’s FDA label does not currently warn about lymphoma. Whether any individual has a claim depends on their medical records and the law of their state.

What do people describe before a CTCL diagnosis is made?

Looking back, most people describe something unremarkable at the time. A patch that kept returning to the same spot. An area that never fully cleared no matter which cream was tried. Skin managed for years suddenly behaving differently in one place. The detail people land on is not that their skin got worse overall, but that one area stopped acting like the rest of it. That is an experience, not a test.

What does “a rash that never heals” actually mean?

People use it to mean an area that follows its own rules: it fades and returns in the same place, it stays when everything else clears, or it takes far longer to settle than it should. Sometimes it is described as dry, scaly, or rough to the touch; sometimes as a small sore or split that keeps reopening. Persistent rashes are common, and the overwhelming majority are not lymphoma. What makes any of it worth mentioning to a doctor is the pattern over time.

What about patches and plaques that keep coming back?

Patch is the word for a flat discolored area; plaque is the word for a thicker, raised one. Patients pick these words up from their own reports and use them precisely. Recurrence in the same location is the feature people describe most often in hindsight — the same shoulder, the same fold, the same forearm. That is worth writing down and showing to a dermatologist. It is not a diagnosis, and plenty of long-standing skin conditions behave the same way.

What about itching that treatment does not touch?

Itch that does not answer to the creams, steroids, or antihistamines that used to work is one of the most exhausting things people in this position describe: sleep lost, skin scratched raw, life organized around it. It is also non-specific. Severe unrelieved itching happens in many conditions and is a reason to tell your doctor plainly that what you are using is not working.

What about lymph node changes?

Swollen glands in the neck, armpit, or groin are usually a response to infection and usually settle. Physicians pay closer attention to nodes that stay enlarged for weeks, grow, or turn up alongside changing skin. If you have noticed something like that, say so at your next appointment rather than trying to work out what it means. The weighing needs an examination.

When do doctors recommend a biopsy?

That call belongs to your dermatologist, and it is made from an examination, not from a web page. Broadly, physicians consider a skin biopsy when a rash does not respond the way it should, keeps recurring in one place, or changes in appearance. It is entirely reasonable to ask directly: is a biopsy worth doing here? Early biopsies frequently come back inconclusive, and one unclear result does not settle the question — repeat biopsies over time are ordinary.

This page is about a lawsuit — it is not medical advice, and filing a claim does not require you to stop taking Dupixent. Decisions about your medication belong with you and your doctor.

Why is this so often mistaken for eczema?

Because early cutaneous T-cell lymphoma and atopic dermatitis can look alike both to the eye and under the microscope. A 2026 editorial in the American Journal of Clinical Dermatology describes “considerable clinical and histopathologic overlap between AD and early-stage MF, which may lead to initial misdiagnosis.” If you spent years misdiagnosed as eczema, that was the reasonable reading of what was in front of everyone, including your dermatologist. It was not something you missed.

What if you were diagnosed after taking Dupixent?

If a qualifying lymphoma diagnosis — mycosis fungoides among them — was made after or during Dupixent use, your records can be reviewed. Being still taking Dupixent changes nothing about that. It also helps to save evidence you already have: packaging, pharmacy paperwork, appointment records.

  • A qualifying lymphoma diagnosis made after or during Dupixent use.
  • No minimum length of Dupixent use is required.
  • Claims may be brought on behalf of someone who has died, through their estate.
  • Not sure which subtype is on your report? That does not end the review.

Marin & Murphy Law Firm is currently accepting Dupixent CTCL cases. A review is confidential and carries no obligation.

Free Confidential Evaluation — No Fee Unless There Is a Recovery

(888) 348-2735

Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

What else do people ask about CTCL symptoms?

What symptoms do people describe before a CTCL diagnosis?

Most commonly: patches or plaques that keep returning in the same place, areas that never fully clear, and itching that treatment does not touch. None of these is specific to lymphoma, and all are far more often something else.

Does a rash that will not go away mean I have lymphoma?

No. Persistent rashes are common and lymphoma is rare — a SEER analysis in JAMA Oncology reported cutaneous T-cell lymphoma at about 8.55 cases per million person-years. A rash that is not behaving is a reason to be seen by a dermatologist, not a reason to assume the worst.

When do doctors recommend a skin biopsy?

That judgment belongs to your dermatologist. In general, physicians consider a biopsy when a rash does not respond as expected, when it keeps returning in the same place, or when the appearance changes. If you are wondering whether a biopsy makes sense for you, ask your doctor directly.

What if I already had a biopsy and it was normal?

A single biopsy that does not show lymphoma does not permanently close the question, and inconclusive results are common in early disease. What that means in your case is a conversation for your treating physicians.

What do lymph node changes mean?

Swollen or tender lymph nodes have many ordinary causes, infections most of all. Doctors take note of nodes that stay enlarged, grow, or appear alongside skin changes. It is information for your physician to weigh, not something to interpret on your own.

Should I stop Dupixent if I am worried?

This firm does not give medical advice and will not tell anyone to stop a medication. That decision belongs with you and your prescribing physician. Having a claim reviewed does not require you to stop or change anything you are taking.

Do I need a diagnosis before contacting a law firm?

The criteria this firm works from turn on a qualifying lymphoma diagnosis made after or during Dupixent use. If you do not have a diagnosis, there is nothing to review yet — and the useful next step is a doctor, not a lawyer.

Is this page medical advice?

No. It is a page about a lawsuit, written to help you recognize your own history in ordinary language. It cannot tell you what you have or what to do next. Only your own physicians can do that.

Free Confidential Evaluation — No Fee Unless There Is a Recovery

(888) 348-2735

Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.

Sources
  • “Incidence Trends of Primary Cutaneous T-Cell Lymphoma in the US From 2000 to 2018: A SEER Population Data Analysis,” JAMA Oncology 2022;8(11):1690–1692 — jamanetwork.com
  • “Dupilumab and Cutaneous T-Cell Lymphoma: A Call for Vigilance, Not Alarm,” American Journal of Clinical Dermatology 2026;27:5–7 — link.springer.com
  • Qualifying-diagnosis list per the referring counsel intake criteria dated February 6, 2026 (on file with Marin & Murphy Law Firm).
  • National Cancer Institute, Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®), Patient Version — cancer.gov
  • American Cancer Society, What Is Skin Lymphoma? — cancer.org